Prestige Consumer Healthcare share price logo

Prestige Consumer Healthcare

NYSE: PBH

$46.95

-0.39

(-0.82%)

as on

Prestige Consumer Healthcare Stock Performance

as on September 12, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $46.48
    $47.75
    downward going graph

    1.00%

    Downside

    1.70%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $42.62
    $71.07
    downward going graph

    9.22%

    Downside

    51.37%

    Upside

    downward going graph

Prestige Consumer Healthcare share price movements today

Previous Close
$47.34
Open
$47.38
Volume
402.5K
Market Cap
$2.5B
Day's Low - High
$46.48 - $47.75
52 Week Low - High
$42.62 - $71.07

Prestige Consumer Healthcare Historical Returns

1 Month Return
-8.11 %
3 Month Return
-0.88 %
1 Year Return
-25.12 %
3 Year Return
-14.11 %
5 Year Return
-8.97 %

Prestige Consumer Healthcare Stock Fundamentals & Key Indicators

Check Prestige Consumer Healthcare market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.5B

EPS (TTM)

4.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.36%

PE Ratio (TTM)

13.64

Industry PE ratio

28.00

PEG Ratio

1.5223

EBITDA

325.4M

Revenue (TTM)

1.1B

Profit Margin

15.57%

Return On Equity TTM

9.12%

Prestige Consumer Healthcare Stock Valuation

Track how Prestige Consumer Healthcare P/E has moved over time to understand its valuation trends.

Prestige Consumer Healthcare in the last 5 years

  • Overview

  • Trends

Lowest (12.21x)

June 30, 2026

Today (13.64x)

September 10, 2026

Industry (28.00x)

September 10, 2026

Highest (18.35x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 13.64x

Prestige Consumer Healthcare vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Prestige Consumer Healthcare with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$2.5B-8.97%13.6415.57%NA
BUY$21.7B141.04%16.7786.14%NA
HOLD$19.4B19.57%-45.8334.83%288.98%
BUY$40.9BNA18.8814.55%134.02%
BUY$31.3B-64.58%12.0670.87%284.12%

Stock Returns calculator for Prestige Consumer Healthcare Stock including INR - Dollar returns

The Prestige Consumer Healthcare stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Prestige Consumer Healthcare investment value today

Current value as on today

₹78,125

Returns

-₹21,875

(-21.87%)

Returns from Prestige Consumer Healthcare Stock

-₹27,814 (-27.81%)

Dollar Impact

₹5,939 (+5.94%)

Analyst Recommendation on Prestige Consumer Healthcare Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Prestige Consumer Healthcare. Average target price of $67.8

Prestige Consumer Healthcare Share Price Target

Get share price movements and forecasts by analysts on Prestige Consumer Healthcare.

What analysts predicted

30.75%UPSIDE

Target Price

$67.8

Current Price

$46.95

Analyzed by

2 Analysts

Target

$67.80

Prestige Consumer Healthcare target price $67.8, a slight upside of 30.75% compared to current price of $46.95. According to 2 analysts rating.

Indian Investors' Interest in Prestige Consumer Healthcare Stock

Search interest for Prestige Consumer Healthcare Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-35% versus previous 30 day period

Prestige Consumer Healthcare Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
276
267
283
290
296
249
274
283
281
265
Gross Profit
151
146
157
161
175
135
154
157
140
136
Operating Income
82
72
84
91
88
71
79
82
75
52
EBITDA
90
79
89
98
91
79
86
80
84
61
Interest Expense
15
13
12
11
10
10
10
10
11
13
Depreciation
7
8
7
6
7
7
7
7
8
8
Income Before Tax
67
58
71
80
73
61
69
61
64
38
Income Tax Expense
17
9
17
19
23
14
26
15
10
9
Net Income
49
49
54
61
50
47
42
46
53
29
Net Profit Margin
17.86%
18.37%
19.18%
21.02%
16.89%
19.02%
15.40%
16.47%
19.15%
10.98%

Prestige Consumer Healthcare Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
882
1,041
975
963
943
1,086
1,127
1,125
1,137
1,088
Gross Profit
500
576
555
552
547
620
625
624
634
574
Operating Income
205
215
67
291
297
329
-22
342
336
309
EBITDA
304
355
98
325
316
358
7
373
361
331
Interest Expense
93
106
105
96
82
64
69
67
47
42
Depreciation
-
33
31
28
30
32
32
30
30
31
Income Before Tax
110
107
-38
191
204
262
-93
276
284
257
Income Tax Expense
41
-232
-2
48
39
57
-11
66
69
67
Net Income
69
339
-35
142
164
205
-82
209
214
190
Net Profit Margin
7.87%
32.61%
-3.67%
14.77%
17.46%
18.90%
-7.30%
18.60%
18.86%
17.48%

Prestige Consumer Healthcare Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
49
54
61
50
47
42
46
53
29
Operating Cash Flow
54
69
65
61
79
57
78
42
70
Investing Cash Flow
-2
-2
-9
-3
-1
-2
-128
-3
-1,063
Financing Cash Flow
-65
-51
-53
-11
-36
-74
-6
-38
1,018
Change in Cash
-12
17
0
47
41
-20
-56
1
25

Prestige Consumer Healthcare Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
339
-35
142
164
205
-82
209
214
190
Operating Cash Flow
210
189
217
235
259
229
248
251
257
Investing Cash Flow
-11
55
-16
-22
-256
-11
-20
-17
-136
Financing Cash Flow
-208
-249
-131
-279
-7
-185
-241
-182
-156
Change in Cash
-9
-5
67
-62
-5
31
-12
51
-34

Mutual Funds that own Prestige Consumer Healthcare Stock

Check out the Mutual Funds with significant holdings in Prestige Consumer Healthcare.

Funds
Holdings
Shares Held
Delaware Group Equity Funds V
8.92308%
4227267
VANGUARD INDEX FUNDS
8.010776%
3795067
Ariel Investment Trust
3.668205%
1737795
DFA INVESTMENT DIMENSIONS GROUP INC
3.24124%
1535522
ALLSPRING FUNDS TRUST
2.090684%
990452

Global Institutional Holdings in Prestige Consumer Healthcare

Funds
Holdings
iShares
11.54%
John Rogers
10.28%
Vanguard
9.69%
Charles Brandes
4.33%
SPDR
2.33%

Insights on Prestige Consumer Healthcare

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 69.3% return, outperforming this stock by 89.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 65.8% return, outperforming this stock by 91.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 283.44M → 265.70M (in $), with an average decrease of 3.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PBH stock has moved down by -10.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 53.92M → 29.17M (in $), with an average decrease of 45.9% per quarter

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
OrganisationPrestige Consumer Healthcare
Headquarters660 White Plains Road, Tarrytown, NY, United States, 10591
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Ronald M. Lombardi CPA
E-voting on sharesClick here to vote

Key Management of Prestige Consumer Healthcare

Name

Title

Mr. Philip David Terpolilli C.F.A.

Director of Investor Relations

Dean Siegal

Director of Communications

Mr. Jose Luis Rosado

Senior Vice President of Quality & Regulatory Affairs

Mr. Ronald M. Lombardi CPA

Chairman, President & CEO

Ms. Christine Sacco CPA

CFO & COO

Mr. William C. P'Pool J.D.

Senior VP, General Counsel & Corporate Secretary

Mr. Adel Mekhail

Executive Vice President of Marketing & Sales

FAQs

What is Prestige Consumer Healthcare share price today?

Prestige Consumer Healthcare share price today is $46.95 as on at the close of the market. Prestige Consumer Healthcare share today touched a day high of $47.75 and a low of $46.48.

What is the 52 week high and 52 week low for Prestige Consumer Healthcare share?

Prestige Consumer Healthcare share touched a 52 week high of $71.07 on and a 52 week low of $42.62 on . Prestige Consumer Healthcare stock price today i.e. is closed at $46.95,which is 33.94% down from its 52 week high and 10.16% up from its 52 week low.

What is Prestige Consumer Healthcare's market capitalisation today?

Prestige Consumer Healthcare market capitalisation is $0.00T as on .

How to invest in Prestige Consumer Healthcare Stock (PBH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Prestige Consumer Healthcare on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Prestige Consumer Healthcare Shares that will get you 0.0319 shares as per Prestige Consumer Healthcare share price of $46.95 per share as on September 12, 2026 at 8:45 am IST.

What is the minimum amount required to buy Prestige Consumer Healthcare Stock (PBH) from India?

Indian investors can start investing in Prestige Consumer Healthcare (PBH) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Prestige Consumer Healthcare stock (as per the Rupee-Dollar exchange rate as on ). Based on Prestige Consumer Healthcare share’s latest price of $46.95 as on September 12, 2026 at 8:45 am IST, you will get 0.2130 shares of Prestige Consumer Healthcare. Learn more about fractional shares .

What are the returns that Prestige Consumer Healthcare has given to Indian investors in the last 5 years?

Prestige Consumer Healthcare stock has given -8.97% share price returns and 29.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?